Bellicum Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BLCM and buy or sell other stocks, ETFs, and their options commission-free!About BLCM
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.
CEODave Maggio
CEODave Maggio
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2004
Founded2004
Employees—
Employees—
BLCM Key Statistics
Market cap889.60K
Market cap889.60K
Price-Earnings ratio-0.06
Price-Earnings ratio-0.06
Dividend yield—
Dividend yield—
Average volume27.22K
Average volume27.22K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.31
52 Week high$1.31
52 Week low$0.06
52 Week low$0.06
Stock Snapshot
With a market cap of 889.6K, Bellicum Pharmaceuticals(BLCM) trades at $0.07. The stock has a price-to-earnings ratio of -0.06.
Bellicum Pharmaceuticals(BLCM) stock opened on 2025-12-14 at —. The price climbed to — and dipped to —.
Bellicum Pharmaceuticals(BLCM) shares are trading with a volume of 0, against a daily average of 27.22K.
In the last year, Bellicum Pharmaceuticals(BLCM) shares hit a 52-week high of $1.31 and a 52-week low of $0.06.
In the last year, Bellicum Pharmaceuticals(BLCM) shares hit a 52-week high of $1.31 and a 52-week low of $0.06.